CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- UPLOAD Other SEC-generated Letter
- SC 13G/A Stake Amended Statement of Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- UPLOAD Other SEC-generated Letter
- 4 Grant or award Director acquired 2,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement · Shareholder rights changed
- 4 Open-market sale Chief Executive Officer sold 50,000 shares at $5.26 ($263,000)
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change
- 8-K Event Material agreement · Acquisition or sale completed
- 10-Q/A Report 10-Q/A
- 10-Q Report Quarterly Report
Page 60 of 74 · 1,465 filings